Home › Funds › IRIDIAN ASSET MANAGEMENT LLC/CT › PGEN

IRIDIAN ASSET MANAGEMENT LLC/CT position in PGEN

PRECIGEN INC · Health Care

IRIDIAN ASSET MANAGEMENT LLC/CT reported holding 3,064,571 shares of PGEN (PRECIGEN INC) in its Q3 2026 13F filing — a position valued at US$26.2M, representing 9.54% of its reported portfolio and ranking #2 among its reported holdings. IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed PGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.06M sh
Reported value held$26.23M
Portfolio Weight9.54%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How IRIDIAN ASSET MANAGEMENT LLC/CT's PGEN position evolved

IRIDIAN ASSET MANAGEMENT LLC/CT first disclosed a stake in PGEN in Q3 2023 at 2,078,220 shares (US$3.0M). The position peaked in Q3 2026 at 3,064,571 shares, worth US$26.2M. Across 13 filings, IRIDIAN ASSET MANAGEMENT LLC/CT increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,064,571 shares valued at US$26.2M — a reduction of -967,392 shares quarter over quarter.. Notable position changes include a 82% increase in Q3 2024 (shares rose 18% over the following quarter), a 39% increase in Q4 2024 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.08M $2.95M New
Q4 2023 2.00M $2.69M Reduce
Q1 2024 2.09M $3.03M Add
Q2 2024 2.07M $3.27M Reduce
Q3 2024 3.78M $3.58M Add
Q4 2024 5.24M $5.87M Add
Q1 2025 4.59M $6.83M Reduce
Q2 2025 4.28M $6.08M Reduce
Q3 2025 3.67M $12.06M Reduce
Q4 2025 3.60M $15.05M Reduce
Q1 2026 3.59M $13.90M Hold
Q2 2026 4.03M $22.98M Add
Q3 2026 3.06M $26.23M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PGEN and 13F data

PGEN (PRECIGEN INC) is a Health Care company. 66 other funds we track also report a position in PGEN — the largest reported positions include Patient Capital Management, LLC (US$153.7M), TANG CAPITAL MANAGEMENT LLC (US$36.6M), Boxer Capital Management, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PGEN

All PGEN fund holders →

FAQ

How long has IRIDIAN ASSET MANAGEMENT LLC/CT held PGEN?

IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed PGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is IRIDIAN ASSET MANAGEMENT LLC/CT's current position in PGEN?

As of Q3 2026, IRIDIAN ASSET MANAGEMENT LLC/CT holds 3.06M shares of PGEN (PRECIGEN INC), valued at $26.23M, representing 9.54% of its reported portfolio and ranking #2.

Has IRIDIAN ASSET MANAGEMENT LLC/CT been buying or selling PGEN?

In the latest 13F filing (Q3 2026), IRIDIAN ASSET MANAGEMENT LLC/CT reduced its position in PGEN. The position peaked in Q3 2026 at 3.06M shares.

Which other funds hold PGEN?

Other major institutional holders of PGEN include Patient Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Boxer Capital Management, LLC, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.